scispace - formally typeset
C

Claudia Gregoriano

Researcher at University of Basel

Publications -  38
Citations -  460

Claudia Gregoriano is an academic researcher from University of Basel. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 28 publications receiving 179 citations. Previous affiliations of Claudia Gregoriano include University Hospital of Basel.

Papers
More filters
Journal ArticleDOI

Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial

TL;DR: Correct inhalation of prescribed medication is associated with improved health status and lung function and should encourage health professionals to provide instructions on correct inhalation technique and to regularly re-evaluate the patients’ inhalation techniques.
Journal ArticleDOI

Role of procalcitonin use in the management of sepsis.

TL;DR: Blood infection marker procalcitonin (PCT) helps in guiding antibiotic use in patients with respiratory infection and sepsis by limiting initiation and by shortening treatment duration and is the best studied biomarker regarding antibiotic stewardship.
Journal ArticleDOI

Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis.

TL;DR: Markers of disease progression such as inflammatory markers, markers for shock and impaired respiratory function provided the most prognostic information regarding severe COVID-19 progression in the sample.
Journal ArticleDOI

The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.

TL;DR: In this paper, the authors investigated the association of MR-proADM levels with in-hospital mortality in logistic regression and discrimination analyses, and showed that an increase of 1 nmol/L was independently associated with a more than fivefold increase in inhospital mortality (adjusted odds ratio of 5.5, 95% confidence interval 1.4-21.4).
Journal ArticleDOI

Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial

TL;DR: Participants assigned to the intervention group had significantly better taking and timing adherence of inhaled medication resulting in a trend towards a decreased frequency of exacerbations, but no effect on time to next exacerbation was observed.